Diaceutics (DXRX)

Sector:

Health Care

Index:

FTSE AIM All-Share

 128.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 168.00
  • 52 Week Low: 108.00
  • Currency: UK Pounds
  • Shares Issued: 84.90m
  • Volume: 0
  • Market Cap: £109.10m
  • RiskGrade: 196
  • Beta: 0.43

Latest Deals

Traded Action Notifier PriceAmountValue
23-Dec-25 Buy Nick Roberts 128.00p 117 £149.76
23-Dec-25 Buy Jordan Clark 128.00p 117 £149.76

Largest Deals (28 days)

Traded Action Notifier PriceAmountValue
23-Dec-25 Buy Jordan Clark 128.00p 117 £149.76
23-Dec-25 Buy Nick Roberts 128.00p 117 £149.76

Director Shareholdings

Notifier Holding Value*
Peter Keeling 15,252,049 £19,598,883
Ryan Gerard Keeling 2,990,643 £3,842,976
Graham Paterson 85,141 £109,406
Nick Roberts 65,535 £84,212
Richard Charles Hindson 63,500 £81,598
Jordan Clark 541 £695

Major Shareholders

Notifier** Holding Value*
Gresham House Asset Management Ltd 14,435,250 £18,549,296
Gresham House 13,243,500 £17,017,898
Canaccord Genuity 8,167,000 £10,494,595
Berenberg Asset Management 5,069,500 £6,514,308
Universal-Investment-Gesellschaft mbH 4,009,764 £5,152,547
Danske Bank A/S 3,379,766 £4,342,999
Elizabeth Considine 3,112,169 £3,999,137
Herald Investment Management 3,011,000 £3,869,135
BlackRock Investment Mgt 2,714,165 £3,487,702
West Elk Capital, LLC 2,543,281 £3,268,116
SLP Innovations Ltd 2,446,327 £3,143,530
Octopus Investments 2,420,500 £3,110,342

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Diaceutics Market Data

Currency UK Pounds
Share Price 128.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 168.00
52 Week Low 108.00
Volume 0
Shares Issued 84.90m
Market Cap £109.10m
Beta 0.43
RiskGrade 196

Diaceutics Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average33.57% below the market average
51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average51.52% below the sector average
Price Trend
29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average29.40% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income Not Available
Growth
48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average48.02% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

Diaceutics Dividends

No dividends found

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

Diaceutics Key Personnel

CEO Ryan Gerard Keeling
CFO Nick Roberts

Top of Page